Concepedia

Author

Stuart Oliver

AstraZeneca (United Kingdom)

Also Known As

Stuart D. Oliver, Stuart Oliver

34

Publications

1.4K

Citations

18

H-Index

39

Concepts

All Affiliations

AstraZeneca (United Kingdom)Covance (United Kingdom)AstraZeneca (United States)AstraZeneca (Brazil)Pfizer (United Kingdom)
SO

About

Stuart Oliver is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

458

2

Health Sciences

1

1

68

3

Biochemistry

1

1

17

4

Cell Biology

1

1

68

5

Gastroenterology

1

1

22

Stuart Oliver

×

23

Publications

1.4K

Citations

18

H-Index

YearCitations

Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects

Renli Teng, Stuart Oliver, Martin A. Hayes,

Drug Metabolism and Disposition

2010

260

Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safety

Lynn Purkins, Nolan Wood, Katie Greenhalgh,

British Journal of Clinical Pharmacology

2003

144

Intravenous Safety and Pharmacokinetics of a Novel Dimerizer Drug, AP1903, in Healthy Volunteers

John D. Iuliucci, Stuart Oliver, Steven K. Morley,

The Journal of Clinical Pharmacology

2001

124

The pharmacokinetics and safety of intravenous voriconazole – a novel wide‐spectrum antifungal agent

Lynn Purkins, Nolan Wood, Katie Greenhalgh,

British Journal of Clinical Pharmacology

2003

115

Pharmacokinetics of Vandetanib: Three Phase I Studies in Healthy Subjects

Paul Martín, Stuart Oliver, Sarah-Jane Kennedy,

Clinical Therapeutics

2011

84

Phase I study of the Aurora B kinase inhibitor barasertib (AZD1152) to assess the pharmacokinetics, metabolism and excretion in patients with acute myeloid leukemia

Mike Dennis, Michelle Davies, Stuart Oliver,

Cancer Chemotherapy and Pharmacology

2012

68

Pharmacokinetics and Tolerability of Gemifloxacin (SB-265805) after Administration of Single Oral Doses to Healthy Volunteers

Ann Allen, Elizabeth Bygate, Stuart Oliver,

Antimicrobial Agents and Chemotherapy

2000

68

Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine

Susanne Johansson, Jessica Read, Stuart Oliver,

Clinical Pharmacokinetics

2014

61

Phase I Study Assessing the Safety and Tolerability of Barasertib (AZD1152) With Low-Dose Cytosine Arabinoside in Elderly Patients With AML

Hagop M. Kantarjian, Mikkael A. Sekeres, Vincent Ribrag,

Clinical Lymphoma Myeloma & Leukemia

2013

58

Pharmacokinetic Drug Interactions with Vandetanib during Coadministration with Rifampicin or Itraconazole

Paul Martin, Stuart Oliver, Jane Robertson,

Drugs in R&D

2011

49

Page 1